Clinical trial
Prevention of Breast Cancer-related Lymphedma With Tacrolimus
NCT04390685 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Breast Cancer-related Lymphedma With Tacrolimus
- Lead sponsor
- Odense University Hospital
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- February 26, 2020
- Completion date
- September 30, 2022
- Enrollment
- 60 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.